Diagnosis of Hemophilia B (Factor IX deficiency) and determination of its severity (mild, moderate, severe) based on the percentage of remaining activity. Differentiating between Hemophilia types (A, B) and other clotting disorders in the presence of a family history or bleeding symptoms. Monitoring the effectiveness of Factor IX replacement therapy (in known patients) and ensuring therapeutic levels are reached. Evaluating the cause of prolonged clotting times in tests such as PTT.

Male children (0-12 years): Especially when signs of abnormal bleeding appear (such as large bruises, joint bleeding) or if there is a known family history of Hemophilia. Adolescents and men: Who have been diagnosed with Hemophilia B for follow-up and to assess treatment efficacy. Individuals of both genders: In rare cases, females may be carriers with mild symptoms or in cases of suspected acquired immune disorder against Factor IX. Chronic patients: Those with Hemophilia B who require regular monitoring before and after surgeries or during bleeding events.

Family history of Hemophilia or bleeding disorders. Large or deep bruises or easy bruising with minor trauma. Frequent or prolonged bleeding from minor cuts, or after tooth extraction or surgical procedures. Spontaneous joint bleeding (e.g., knees, elbows) causing pain and swelling. Unexplained bleeding from the nose (epistaxis) or gums. Significant prolongation of activated partial thromboplastin time (aPTT) in routine blood tests.

6% - 49%: Mild deficiency. 1% - 5%: Moderate deficiency. Less than 1%: Severe deficiency.

Factor IX Coagulation Test | Lahalak Platform

An essential test to measure Factor IX activity, helping diagnose Hemophilia B and ensuring your blood's natural ability to clot properly and safely.

Scientific name: Factor IX Coagulation Activity Test

A specific test in the context of evaluating coagulation disorders that measures the functional activity of Factor IX (Factor IX) in plasma, expressed as a percentage of normal activity. Factor IX is a crucial protein in the intrinsic pathway of blood coagulation. Its deficiency or functional defect is the direct cause of Hemophilia B.

Factor IX Coagulation Activity Test - Check Factor IX Clotting

Service type Laboratory test (Blood)

Duration 10-15 minutes

Fasting Fasting is not required

Included Services

Factor IX Coagulation Activity Test

Medical Service Information

Purpose Test

Diagnosis of Hemophilia B (Factor IX deficiency) and determination of its severity (mild, moderate, severe) based on the percentage of remaining activity.
Differentiating between Hemophilia types (A, B) and other clotting disorders in the presence of a family history or bleeding symptoms.
Monitoring the effectiveness of Factor IX replacement therapy (in known patients) and ensuring therapeutic levels are reached.
Evaluating the cause of prolonged clotting times in tests such as PTT.

Recommended groups

Male children (0-12 years): Especially when signs of abnormal bleeding appear (such as large bruises, joint bleeding) or if there is a known family history of Hemophilia.
Adolescents and men: Who have been diagnosed with Hemophilia B for follow-up and to assess treatment efficacy.
Individuals of both genders: In rare cases, females may be carriers with mild symptoms or in cases of suspected acquired immune disorder against Factor IX.
Chronic patients: Those with Hemophilia B who require regular monitoring before and after surgeries or during bleeding events.

Symptoms indicative

Family history of Hemophilia or bleeding disorders.
Large or deep bruises or easy bruising with minor trauma.
Frequent or prolonged bleeding from minor cuts, or after tooth extraction or surgical procedures.
Spontaneous joint bleeding (e.g., knees, elbows) causing pain and swelling.
Unexplained bleeding from the nose (epistaxis) or gums.
Significant prolongation of activated partial thromboplastin time (aPTT) in routine blood tests.

Frequently Asked Questions (FAQs)

What is the difference between Hemophilia A and Hemophilia B? Both are inherited bleeding disorders linked to the X chromosome, but they differ in the deficient clotting factor. Hemophilia A (more common) results from a deficiency of Factor VIII, whereas Hemophilia B (Christmas disease) results from a deficiency of Factor IX. The clinical symptoms are similar, and distinguishing between them requires specialized clotting tests.
How is Factor IX activity interpreted? The result is given as a percentage of normal activity (100%). Normal: 50-150% Mild Hemophilia: 6-49% (bleeding usually after trauma or surgery). Moderate Hemophilia: 1-5% (occasional spontaneous bleeding, bleeding after minor trauma). Severe Hemophilia:
Normal: 50-150%
Mild Hemophilia: 6-49% (bleeding usually after trauma or surgery).
Moderate Hemophilia: 1-5% (occasional spontaneous bleeding, bleeding after minor trauma).
Severe Hemophilia: